SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000769993-20-000081
Filing Date
2020-01-31
Accepted
2020-01-31 12:05:11
Documents
1
Group Members
GOLDMAN SACHS & CO. LLC

Document Format Files

Seq Description Document Type Size
1 13G AMAG PHARMACEUTICALS 13G_AmagPharma.txt SC 13G 21874
  Complete submission text file 0000769993-20-000081.txt   23718
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Subject) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-38286 | Film No.: 20564071
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 212-902-1000
GOLDMAN SACHS GROUP INC (Filed by) CIK: 0000886982 (see all company filings)

IRS No.: 134019460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies